多囊卵巢综合征发病机制探讨
Pathogenesis of Polycystic Ovary Syndrome
DOI: 10.12677/ACM.2021.114244, PDF,   
作者: 朱海静, 李泳诗, 欧湘红*:南华大学教学医院广东省第二人民医院,广东 广州;广东省第二人民医院生殖医学中心生殖力保护实验室,广东 广州;李妍楚, 杜文豪, 杨琳俐:广东省第二人民医院生殖医学中心生殖力保护实验室,广东 广州
关键词: 多囊卵巢综合征HPO轴功能紊乱肠道菌群生物节律胰岛素抵抗Polycystic Ovary Syndrome HPO Axis Dysfunction Intestinal Flora Circadian Rhythm Insulin Resistance
摘要: 多囊卵巢综合征(polycystic ovary syndrome, PCOS)是育龄女性最常见的疾病,整体患病率为10%~19.9%,具有多种短期和长期不良后果,是一种影响全世界数百万妇女的生殖、内分泌和代谢紊乱性疾病。至今该病的发生机制仍不明确,大多数学者认为PCOS为遗传易感基因与环境因素相互作用的结果,对该病的治疗策略及对远期并发症的管理方法仍然有限。本文是对与PCOS发病相关的潜在病因机制的系统综述,通过对发病机制的探索,寻找未来治疗的新靶点、新方向。
Abstract: Polycystic ovary syndrome (PCOS) is the most common disease in women of childbearing age, which overall prevalence rate is 10%~19.9%. It is a pathema that causes a variety of short-term and long-term adverse consequences in reproduction, endocrine and metabolism that affects millions of women all over the world. Nevertheless, the pathogenesis of PCOS is still unclear. Most experts believe that PCOS is the result of the interaction of genetic susceptibility genes and environmental factors. The treatment strategies and management methods of long-term complications of PCOS are still limited. This article is a systematic review of the underlying pathogenesis of PCOS targeting for looking for new targets and new directions of treatment in the future through the exploration of the pathogenesis.
文章引用:朱海静, 李泳诗, 李妍楚, 杜文豪, 杨琳俐, 欧湘红. 多囊卵巢综合征发病机制探讨[J]. 临床医学进展, 2021, 11(4): 1703-1709. https://doi.org/10.12677/ACM.2021.114244

参考文献

[1] Lizneva, D., Suturina, L., Walker, W., et al. (2016) Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome. Fertility and Sterility, 106, 6-15. [Google Scholar] [CrossRef] [PubMed]
[2] Fauser, B.C., Tarlatzis, B.C., Rebar, R.W., et al. (2012) Consensus on Women’s Health Aspects of Polycystic Ovary Syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility, 97, 28-38. [Google Scholar] [CrossRef] [PubMed]
[3] Mills, G., Badeghiesh, A., Suarthana, E., et al. (2020) Polycystic Ovary Syndrome as an Independent Risk Factor for Gestational Diabetes and Hypertensive Disorders of Pregnancy: A Population-Based Study on 9.1 Million Pregnancies. Human Reproduction, 35, 1666-1674. [Google Scholar] [CrossRef] [PubMed]
[4] Cooney, L.G. and Dokras, A. (2018) Beyond Fertility: Polycystic Ovary Syndrome and Long-Term Health. Fertility and Sterility, 110, 794-809. [Google Scholar] [CrossRef] [PubMed]
[5] (2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome. Fertility and Sterility, 81, 19-25. [Google Scholar] [CrossRef] [PubMed]
[6] Azziz, R. (2016) PCOS in 2015: New Insights into the Genetics of Polycystic Ovary Syndrome. Nature Reviews Endocrinology, 12, 74-75. [Google Scholar] [CrossRef] [PubMed]
[7] Azziz, R. (2018) Polycystic Ovary Syndrome. Obstetrics & Gynecology, 132, 321-336. [Google Scholar] [CrossRef
[8] Blank, S.K., McCartney, C.R. and Marshall, J.C. (2006) The Origins and Sequelae of Abnormal Neuroendocrine Function in Polycystic Ovary Syndrome. Human Reproduction Update, 12, 351-361. [Google Scholar] [CrossRef] [PubMed]
[9] Stubbs, S.A., Hardy, K., Da, S.P., et al. (2005) Anti-Mullerian Hormone Protein Expression Is Reduced during the Initial Stages of Follicle Development in Human Polycystic Ovaries. The Journal of Clinical Endocrinology & Metabolism, 90, 5536-5543. [Google Scholar] [CrossRef] [PubMed]
[10] Fauser, B.C. and Van Heusden, A.M. (1997) Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences. Endocrine Reviews, 18, 71-106. [Google Scholar] [CrossRef] [PubMed]
[11] Hsieh, M., Thao, K. and Conti, M. (2011) Genetic Dissection of Epidermal Growth Factor Receptor Signaling during Luteinizing Hormone-Induced Oocyte Maturation. PLoS ONE, 6, e21574. [Google Scholar] [CrossRef] [PubMed]
[12] Valkenburg, O., Uitterlinden, A.G., Piersma, D., et al. (2009) Genetic Polymorphisms of GnRH and Gonadotrophic Hormone Receptors Affect the Phenotype of Polycystic Ovary Syndrome. Human Reproduction, 24, 2014-2022. [Google Scholar] [CrossRef] [PubMed]
[13] Rosenfield, R.L. and Ehrmann, D.A. (2016) The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine Reviews, 37, 467-520. [Google Scholar] [CrossRef] [PubMed]
[14] Li, T., Mo, H., Chen, W., et al. (2017) Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome. Reproductive Sciences, 24, 646-655. [Google Scholar] [CrossRef] [PubMed]
[15] Webber, L.J., Stubbs, S., Stark, J., et al. (2003) Formation and Early Development of Follicles in the Polycystic Ovary. The Lancet, 362, 1017-1021. [Google Scholar] [CrossRef
[16] Zeng, X., Xie, Y.J., Liu, Y.T., et al. (2020) Polycystic Ovarian Syndrome: Correlation between Hyperandrogenism, Insulin Resistance and Obesity. Clinica Chimica Acta, 502, 214-221. [Google Scholar] [CrossRef] [PubMed]
[17] Kraemer, W.J., Ratamess, N.A., Hymer, W.C., et al. (2020) Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth with Exercise. Frontiers in Endocrinology (Lausanne), 11, 33. [Google Scholar] [CrossRef] [PubMed]
[18] Dunaif, A. (1997) Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis. Endocrine Reviews, 18, 774-800. [Google Scholar] [CrossRef] [PubMed]
[19] Lan, C.W., Chen, M.J., Tai, K.Y., et al. (2015) Functional Microarray Analysis of Differentially Expressed Genes in Granulosa Cells from Women with Polycystic Ovary Syndrome Related to MAPK/ERK Signaling. Scientific Reports, 5, Article No. 14994. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, M.J., Chou, C.H., Chen, S.U., et al. (2015) The Effect of Androgens on Ovarian Follicle Maturation: Dihydrotestosterone Suppress FSH-Stimulated Granulosa Cell Proliferation by Upregulating PPARgamma-Dependent PTEN Expression. Scientific Reports, 5, Article No. 18319. [Google Scholar] [CrossRef] [PubMed]
[21] Liu, H., Luo, L.L., Qian, Y.S., et al. (2009) FOXO3a Is Involved in the Apoptosis of Naked Oocytes and Oocytes of Primordial Follicles from Neonatal Rat Ovaries. Biochemical and Biophysical Research Communications, 381, 722-727. [Google Scholar] [CrossRef] [PubMed]
[22] Salehi, R., Mazier, H.L., Nivet, A.L., et al. (2020) Ovarian Mitochondrial Dynamics and Cell Fate Regulation in an Androgen-Induced Rat Model of Polycystic Ovarian Syndrome. Scientific Reports, 10, Article No. 1021. [Google Scholar] [CrossRef] [PubMed]
[23] Jin, J., Ma, Y., Tong, X., et al. (2020) Metformin Inhibits Testosterone-Induced Endoplasmic Reticulum Stress in Ovarian Granulosa Cells via Inactivation of p38 MAPK. Human Reproduction, 35, 1145-1158. [Google Scholar] [CrossRef] [PubMed]
[24] Salley, K.E., Wickham, E.P., Cheang, K.I., et al. (2007) Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess Society. The Journal of Clinical Endocrinology & Metabolism, 92, 4546-4556. [Google Scholar] [CrossRef] [PubMed]
[25] Cassar, S., Misso, M.L., Hopkins, W.G., et al. (2016) Insulin Resistance in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Euglycaemic-Hyperinsulinaemic Clamp Studies. Human Reproduction, 31, 2619-2631. [Google Scholar] [CrossRef] [PubMed]
[26] Hansen, S.L., Svendsen, P.F., Jeppesen, J.F., et al. (2019) Molecular Mechanisms in Skeletal Muscle Underlying Insulin Resistance in Women Who Are Lean with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 104, 1841-1854. [Google Scholar] [CrossRef] [PubMed]
[27] Diamanti-Kandarakis, E. and Dunaif, A. (2012) Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications. Endocrine Reviews, 33, 981-1030. [Google Scholar] [CrossRef] [PubMed]
[28] Tosi, F., Dal Molin, F., Zamboni, F., et al. (2020) Serum Androgens Are Independent Predictors of Insulin Clearance but Not of Insulin Secretion in Women with PCOS. The Journal of Clinical Endocrinology & Metabolism, 105, dgaa095. [Google Scholar] [CrossRef] [PubMed]
[29] Kelly, C.C., Lyall, H., Petrie, J.R., et al. (2001) Low Grade Chronic Inflammation in Women with Polycystic Ovarian Syndrome. The Journal of Clinical Endocrinology & Metabolism, 86, 2453-2455. [Google Scholar] [CrossRef] [PubMed]
[30] Vgontzas, A.N., Trakada, G., Bixler, E.O., et al. (2006) Plasma Interleukin 6 Levels Are Elevated in Polycystic Ovary Syndrome Independently of Obesity or Sleep Apnea. Metabolism, 55, 1076-1082. [Google Scholar] [CrossRef] [PubMed]
[31] Gonzalez, F., Rote, N.S., Minium, J., et al. (2006) In Vitro Evidence That Hyperglycemia Stimulates Tumor Necrosis Factor-Alpha Release in Obese Women with Polycystic Ovary Syndrome. Journal of Endocrinology, 188, 521-529. [Google Scholar] [CrossRef] [PubMed]
[32] Li, S., Zhao, L. and Wan, X.H. (2017) A Missense Variant rs4645843 in TNF-alpha Gene Is a Risk Factor of Polycystic Ovary Syndrome in the Uygur Population. The Tohoku Journal of Experimental Medicine, 243, 95-100. [Google Scholar] [CrossRef] [PubMed]
[33] Liu, R., Zhang, C., Shi, Y., et al. (2017) Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome. Frontiers in Microbiology, 8, 324. [Google Scholar] [CrossRef] [PubMed]
[34] Egshatyan, L., Kashtanova, D., Popenko, A., et al. (2016) Gut Microbiota and Diet in Patients with Different Glucose Tolerance. Endocrine Connections, 5, 1-9. [Google Scholar] [CrossRef
[35] Cani, P.D., Amar, J., Iglesias, M.A., et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance. Diabetes, 56, 1761-1772. [Google Scholar] [CrossRef] [PubMed]
[36] Qi, X., Yun, C., Sun, L., et al. (2019) Gut Microbiota-Bile Acid-Interleukin-22 Axis Orchestrates Polycystic Ovary Syndrome. Nature Medicine, 25, 1225-1233. [Google Scholar] [CrossRef] [PubMed]
[37] Goodarzi, M.O., Dumesic, D.A., Chazenbalk, G., et al. (2011) Polycystic Ovary Syndrome: Etiology, Pathogenesis and Diagnosis. Nature Reviews Endocrinology, 7, 219-231. [Google Scholar] [CrossRef] [PubMed]
[38] Mykhalchenko, K., Lizneva, D., Trofimova, T., et al. (2017) Genetics of Polycystic Ovary Syndrome. Expert Reviews Molecular Diagnostics, 17, 723-733. [Google Scholar] [CrossRef] [PubMed]
[39] Cui, L., Zhao, H., Zhang, B., et al. (2013) Genotype-Phenotype Correlations of PCOS Susceptibility SNPs Identified by GWAS in a Large Cohort of Han Chinese Women. Human Reproduction (Oxford), 28, 538-544. [Google Scholar] [CrossRef] [PubMed]
[40] Langley-Evans, S.C., Bellinger, L. and McMullen, S. (2005) Animal Models of Programming: Early Life Influences on Appetite and Feeding Behaviour. Maternal & Child Nutrition, 1, 142-148. [Google Scholar] [CrossRef] [PubMed]
[41] Martin-Gronert, M.S. and Ozanne, S.E. (2005) Programming of Appetite and Type 2 Diabetes. Early Human Development, 81, 981-988. [Google Scholar] [CrossRef] [PubMed]
[42] Homburg, R., Gudi, A., Shah, A., et al. (2017) A Novel Method to Demonstrate That Pregnant Women with Polycystic Ovary Syndrome Hyper-Expose Their Fetus to Androgens as a Possible Stepping Stone for the Developmental Theory of PCOS. A Pilot Study. Reproductive Biology and Endocrinology, 15, 61. [Google Scholar] [CrossRef] [PubMed]
[43] Raperport, C. and Homburg, R. (2019) The Source of Polycystic Ovarian Syndrome. Clinical Medicine Insights: Reproductive Health, 13, Article ID: 1186599915. [Google Scholar] [CrossRef] [PubMed]
[44] Cheng, M.Y., Bullock, C.M., Li, C., et al. (2002) Prokineticin 2 Transmits the Behavioural Circadian Rhythm of the Suprachiasmatic Nucleus. Nature, 417, 405-410. [Google Scholar] [CrossRef] [PubMed]
[45] Wang, W., Yin, L., Bai, L., et al. (2017) Bmal1 Interference Impairs Hormone Synthesis and Promotes Apoptosis in Porcine Granulosa Cells. Theriogenology, 99, 63-68. [Google Scholar] [CrossRef] [PubMed]
[46] Sharma, A., Laurenti, M.C., Dalla, M.C., et al. (2017) Glucose Metabolism during Rotational Shift-Work in Healthcare Workers. Diabetologia, 60, 1483-1490. [Google Scholar] [CrossRef] [PubMed]
[47] Simon, S.L., McWhirter, L., Diniz, B.C., et al. (2019) Morning Circadian Misalignment Is Associated with Insulin Resistance in Girls with Obesity and Polycystic Ovarian Syndrome. The Journal of Clinical Endocrinology & Metabolism, 104, 3525-3534. [Google Scholar] [CrossRef] [PubMed]